Innovation -

Translational
07.01.2026 Leading group in brain metastasis research predicts mid-term advances that will improve patients’ lives In his conferences, Manuel Valiente asks the audience which results from his laboratory at the...

Innovation
10.10.2025 From a Nobel Prize discovery to antibodies generating millions for a Spanish public research centre This year’s Nobel Prize in Physiology or Medicine has just been awarded to those who discovered...

Gonçalo Bernardes. / Laura M. Lombardía. CNIO

Translational
31.07.2025 Nature Communications. CNIO researcher develops a test aimed to detect early-stage tumors with a blood sample Current methods for cancer diagnosis are based on identifying biomarkers – molecules that...

CNIO researcher Marisol Soengas (left) and Marisol Quintero, CEO of Highlight Therapeutics, at the entrance of the National Cancer Research Centre (CNIO). /Scienseed

Translational
15.07.2025 New clinical trial targets the most common form of skin cancer with a compound based on CNIO discoveries Around 15 years ago, in 2009, the team led by Marisol Soengas at the Spanish National Cancer...

Translational
04.03.2025 What is genomic information and why is it important for precision medicine? The European project Genome of Europe (GoE) will generate the most exhaustive genetic database of...

From the left: Sonia Martínez, Joaquín Pastor y Carmen Blanco, researchers of the Experimental Therapies program at CNIO, with Roke Oruezabal, from CNIO’s Innovation program. / E. Sánchez. CNIO

Translational
19.03.2024 First ‘CNIO Investors Day’ to help bridge the gap between cancer research and patient treatment A dozen venture capital firms, as well as funding and consulting firms, have listened carefully to...

Innovation
10.12.2020 Fundación Banco Santander and IE University support CNIO researchers in transforming their findings into business opportunities Fundación Banco Santander is giving support to six scientists from the Spanish National Cancer...

Basic Research
08.10.2020 Nature Communications. CNIO scientists succeed in reprogramming the CRISPR system in mice to eliminate tumour cells without affecting healthy cells The CRISPR/Cas9 gene-editing tool is one of the most promising approaches to advancing treatments of...

Translational
02.07.2020 The EMBO Journal. A quick and simple technology to improve the effectiveness of stem cells in regenerative medicine developed Stem cells have been holding great promise for regenerative medicine for years. In the last decade,...